Veno-venous ECLS rescue for a heart transplant recipient with COVID-19, a case report.
Perfusion
; : 2676591231154120, 2023 Jan 30.
Article
in English
| MEDLINE | ID: covidwho-2223984
ABSTRACT
The potential for increased rates of morbidity of SARS-CoV-2 within immunocompromised populations has been of concern since the pandemic's onset. Transplant providers and patients can face particularly challenging situations, in the current settings as data continues to emerge for the prevention and treatment of the immunocompromised subpopulation. This case report details a patient 9-months post orthotopic heart transplant that developed SARS-CoV-2 infection despite two prior doses of the Pfizer-BioNtech COVID-19 vaccine, and had successful rescue from refractory hypoxemia with veno-venous extracorporeal membrane oxygenation (VV ECLS).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Topics:
Vaccines
Language:
English
Journal:
Perfusion
Journal subject:
Cardiology
Year:
2023
Document Type:
Article
Affiliation country:
02676591231154120
Similar
MEDLINE
...
LILACS
LIS